Thermo Fisher Scientific Continues Collaboration to Support Biopharmaceutical Discovery and Development

Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments SAN JOSE, Calif. – Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier, announce the [...]

Optibrium Adds Augmented Intelligence for Compound Design to its StarDrop Small Molecule Drug Discovery Software

New Inspyra module combines chemists’ expertise with exploratory capabilities of automated compound design Inspyra provides drug designers direct access to powerful AI capabilities, supporting established workflow CAMBRIDGE, UK: Optibrium Ltd, a leading developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, [...]

Quantabio Launches Ultra-Fast RNA Library Prep Kit with Integrated Ribosomal RNA and Globin Depletion for Precision Oncology Applications

sparQ RNA-Seq HMR Kit generates high-quality Illumina® NGS sequencer-ready libraries from intact or degraded samples in a single day BEVERLY, Mass. – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the commercial availability of the sparQ RNA-Seq HMR Kit, an [...]

Element Partners with Interpretation Expert Genoox to Validate the AVITI™ System for the RUGD Application

Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Genoox, a community-driven genomic data platform, to demonstrate the clinical potential of the AVITI™ system for rare and undiagnosed disease research, using whole-genome sequencing. An initial study, in collaboration with Dr. Radha Ayyagari, Professor of Ophthalmology and Pathology at the [...]

Quanterix Announces New Agreements With Lilly To Advance Alzheimer’s Disease Diagnosis And Treatment

License agreement provides Quanterix access to Lilly’s P-tau217 antibody technology, creating pathways for plasma-based biomarkers for use in Alzheimer’s disease; Establishes framework for future collaboration and supports development of Quanterix tests to advance diagnosing and treating life-threatening diseases Billerica, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision [...]

Quanterix Announces Executive Leadership Succession Plan

Masoud Toloue, President of Quanterix and Diagnostics, to Become CEO and Join Board of Directors Kevin Hrusovsky, Chairman and CEO of Quanterix, to Assume Role as Executive Chairman of the Board Moves are Designed to Propel the Precision Health Vision and Catalyze the Next Chapter of Growth and Impact Billerica, Mass. – Quanterix Corporation (NASDAQ: QTRX), [...]

CVC maintains strong US patent portfolio covering CRISPR/Cas9 despite PTAB ruling

Dublin/Ireland: ERS Genomics announced today that the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (“PTAB”) confirmed that its decision regarding priority of invention between the Broad Institute and the University of California, the University of Vienna, and Emmanuelle Charpentier (collectively, CVC) was focused on single-guide CRISPR/Cas9 systems in eukaryotic cells, and has [...]

Mission Bio Announces its First Single-Cell Tapestri Center of Excellence for Solid Tumor Research

Pioneering cancer pathologist Jorge Reis-Filho’s lab at Memorial Sloan Kettering Cancer Center to develop best practices integrating Tapestri single-cell multi-omics capabilities SOUTH SAN FRANCISCO — Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced its first Center of Excellence, located at Memorial Sloan Kettering Cancer Center (MSK) and run by Jorge Reis-Filho, MD, [...]

Cytiva moves quickly on mRNA technology by building its first FlexFactory platform for oligonucleuotide production for General Biol

Small nucleic acid therapeutics can greatly reduce the uncertainty of drug development while shortening processing time. First-ever FlexFactory™ platform for oligonucleotide production boosts the safety, efficiency, and speed of General Biol’s oligonucleotide CDMO business. Shanghai, China - Cytiva, a global life sciences leader, is building the first-ever FlexFactory platform for oligonucleotide production for General Biol [...]

BD Names William ‘Bill’ Brown to Board of Directors

FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of William "Bill" Brown to its board of directors, effective Feb. 28, 2022. Brown, 59, is currently the executive chair of L3Harris Technologies, a global aerospace and technology innovator with $18 billion in annual revenue and [...]

Access IBO on Knowledge Center